Amplifications of MYC (four cases), MDM2 (two cases), MDM4 (two cases), and several other genes were identified with the Illumina TruSight Tumor 170 panel in a subset of tumors (Supplementary Table S2). The gene discussed is MDM2; the disease is neoplasm.